Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in acute graft versus host disease.

Ernst Holler1

  • 1Department of Haematology/Oncology, University Medical Centre, Regensburg, Germany. ernst.holler@klinik.uni-regensburg.de

Current Opinion in Hematology
|September 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue-Based Transcriptomic Profiling of Gastrointestinal Graft Versus Host Disease Reveals Immune and MicroRNA Dysregulation.

International journal of molecular sciences·2026
Same author

Chronic graft-versus-host disease: Current situation and unmet needs - A European position statement.

Bone marrow transplantation·2026
Same author

Proposal for Diagnostic Criteria for Manifestations of Chronic Graft-versus-Host Disease in Peripheral Nervous System and Muscles.

Transplantation and cellular therapy·2026
Same author

GVHD and GRFS in patients with acute myeloid leukemia undergoing allogeneic HCT with treosulfan- versus reduced-intensity busulfan-based conditioning: a subgroup analysis of a randomized phase 3 trial.

Haematologica·2026
Same author

Proposal for Diagnostic Criteria for Manifestations of Chronic Graft-versus-Host Disease in the Central Nervous System.

Transplantation and cellular therapy·2026
Same author

Microbiotherapy and fecal microbiota transplantation in hematology-oncology: a European clinical perspective to navigate the evolving regulatory framework and the emergence of a new therapeutic class.

Bone marrow transplantation·2025

This review covers new cellular and molecular insights into acute graft versus host disease (GVHD). Understanding early GVHD events offers hope for improved, preemptive treatment strategies.

Area of Science:

  • Hematology
  • Immunology
  • Transplantation

Background:

  • Acute graft versus host disease (GVHD) remains a significant challenge in hematopoietic stem cell transplantation.
  • Understanding the complex cellular and molecular mechanisms of GVHD is crucial for improving patient outcomes.

Purpose of the Study:

  • To review experimental and clinical studies on acute GVHD.
  • To highlight recent advances in the understanding of GVHD induction, modulation, and treatment.

Main Methods:

  • Comprehensive literature review of experimental and clinical studies.
  • Analysis of recent findings on cellular players and molecular targets in GVHD.

Main Results:

  • Identified novel cellular players (e.g., regulatory T cells, mesenchymal stem cells) and molecules involved in GVHD.

Related Experiment Videos

  • Highlighted the role of antigen-presenting cells in GVHD and graft-versus-leukemia effects.
  • Emphasized the importance of innate immunity receptors, homing molecules, and chemokines in regulating cellular responses.

    • Conclusions:

    • Enhanced understanding of early GVHD events is key to developing risk-adapted and preemptive treatment strategies.
    • New cellular therapies and molecular targets offer promising avenues for GVHD prophylaxis and treatment.